Wiki

Platelet Count

Platelet Count

Longitudinal Data

Date Value Flag Context/Notes Source
2026-06-06 241 N KIMS — Bill L042743426. Stable normal −11K from June 1. MPV 10.4 (N). Concurrent WBC 2500 (L — recovering), ANC 1240 (L — moderate neutropenia, improved), Hb 12.1 (N — RECOVERED). Dr. Bijay. Collected 10:50 AM. raw/labs/2026-06-07_Ishamma_T_M_1.pdf
2026-06-01 252 N KIMS — Bill L041256126. FULLY RECOVERED +145K from May 27. MPV 11.1 (upper normal). Concurrent WBC 2200 (L — deepest nadir), ANC 990 (L — SEVERE NEUTROPENIA), Hb 11.3 (L). Confirms lineage dissociation — platelets recovered ~10 days before granulocytes. Dr. Bijay. Collected 11:11 AM. raw/labs/2026-06-01_Ishamma_T_M.pdf
2026-05-27 107 L KIMS — Bill L040020926. Slight rise +4K from May 23. MPV 11 (upper normal). Concurrent WBC 2400 (L — leukopenia), ANC 1460 (L), Hb 12.0 (N — first normal). Dr. Bijay. raw/labs/20260527_Ishamma T M 1 5-27-2.pdf
2026-05-23 117 L KIMS — Bill L038904126. +14K from May 17. MPV 10. Concurrent WBC 3500 (L), ANC 2430 (N borderline), Hb 11.6 (L). Smear checked. Dr. Bijay. raw/labs/20260527_Ishamma T M 5-27-1.pdf
2026-05-17 103 L KIMS — Bill L037179526. Continued thrombocytopenia, −10K from May 11. MPV 10.4. Concurrent WBC 4600 (N), ANC 3400 (N), Hb 9.9 (severe drop). Dr. Bijay. raw/labs/2026-05-17_Ishamma_T_M_1.pdf
2026-05-11 113 L KIMS — Bill L035372426. Sharp drop from 213K (May 4) — new thrombocytopenia. MPV 9.8. Concurrent WBC 5700 (N), ANC 3950 (N). Dr. Bijay. raw/labs/2026-05-11_Ishamma_T_M_A.pdf
2026-05-04 213 N KIMS — Bill L033433126. Stable normal, +17K from Apr 27. MPV 9.8. Concurrent WBC 4000 (recovered), ANC 2360 (recovered). raw/assets/2026-05-04_Ishamma_T_M.pdf
2026-04-27 196 N KIMS — Bill L031606726. Strong recovery from 99K. MPV 10.3. Concurrent WBC 3000 (L), ANC 1990 (L). raw/labs/20260427_Ishamma T M 1 ok.pdf
2026-04-20 99 L KIMS — Bill L029731026. Thrombocytopenic. 20260420_Ishamma T M today.pdf
2026-04-13 140 L KIMS Ishamma T M 1.pdf
2026-04-06 131 L KIMS Ishamma T M.pdf
2026-03-30 164 N KIMS Ishamma T M 2.pdf
2026-03-25 279 N KIMS Ishamma T M 1 2.pdf
2026-03-18 102 L KIMS Ishamma T M 1 3.pdf
2026-03-12 78 L KIMS Ishamma T M 1 4.pdf
2026-03-05 102 L KIMS Ishamma T M 3.pdf
2026-03-02 101 L KIMS Ishamma T M 4.pdf
2026-02-25 106 L KIMS Ishamma T M 5.pdf
2026-02-23 80 L DDRC Report For Accession No 4170ZB001398.pdf
2026-02-20 150 N DDRC borderline 4170ZB0011814170_849900t.pdf
2026-02-17 149 L KIMS Ishamma 1.pdf
2026-02-10 262 N KIMS Ishamma T M 6.pdf
2026-02-04 300 N KIMS Ishamma T M 1 5.pdf
2026-01-31 225 N KIMS Ishamma T M 7.pdf
2026-01-28 248 N KIMS Ishamma T M 1 6.pdf
2026-01-25 224 N KIMS Ishamma T M 8.pdf
2026-01-22 257 N KIMS Ishamma T M 9.pdf
2026-01-19 358 N KIMS Ishamma T M 1 7.pdf
2026-01-16 327 N KIMS Ishamma T M 10.pdf
2025-11-28 45 L KIMS - Severe File1000384802.pdf
2025-11-19 70 L DDRC CCR_4182YK007572_296266q.pdf
2022-11-25 230 N JDC Lab (Jothydev's) — Impedance. 2.3 lakhs/cumm = 230K. Ref 150–450K. Normal. 2 months after reactive thrombocytosis. raw/assets/20260429_IMG_9751.jpeg
2022-09-27 501 H DDRC SRL - Reactive thrombocytosis 4182VI0131054182_816476x.pdf

Trend Analysis

Platelets were severely depressed at AML diagnosis, reaching 45K in late November 2025 (well below the critical threshold for spontaneous bleeding risk). With Aza-Ven treatment initiation, platelet counts recovered robustly into the normal range by January 2026, peaking at 358K on 2026-01-19. A clear cyclical pattern has emerged consistent with treatment-induced myelosuppression: platelets dropped to 78-106K through late February into early March 2026, recovered to 279K by late March, then dropped again to 131-140K in early April 2026, then further to 99K on Apr 20 — below the 100K threshold.

Late April-Early May recovery and May 11 drop: Platelets recovered strongly:
- Apr 20: 99K (thrombocytopenic, bleeding risk concern)
- Apr 27: 196K (+97K in 7 days, back to normal)
- May 4: 213K (+17K, stable normal — bleeding risk resolved)
- May 11: 113K (−100K in 7 days) — NEW THROMBOCYTOPENIA

**Sharp Platelet Drop: 213K → 113K (May 4 → May 11)**

Platelets dropped by 100,000/cumm in 7 days, falling from normal (213K) back into thrombocytopenic range (113K, below 150K threshold). This represents a 47% decline and is consistent with early cyclical Aza-Ven myelosuppression. Critically, this drop occurred while WBC (5700) and ANC (3950) remained normal, demonstrating classic dissociated lineage kinetics — platelets drop first, followed by neutrophils 3-7 days later. Bleeding risk is now elevated (spontaneous bleeding risk threshold <50K, procedural/trauma risk <100K). Monitor closely. WBC/ANC nadir likely imminent within 3-7 days. See Wbc, Anc.

Pattern recognition: This is the same pattern seen in April: platelets dropped to 99K on Apr 20, then WBC/ANC dropped 7 days later (Apr 27: WBC 3000, ANC 1990). Current kinetics: platelet nadir May 11 (113K), WBC/ANC nadir expected ~May 20-24. Infection risk will rise when ANC drops.

May-June 2026 recovery: After the May 11-17 nadir, platelets have fully recovered:
- May 11: 113K (nadir — sharp drop from 213K on May 4)
- May 17: 103K (−10K, absolute nadir)
- May 23: 117K (+14K — recovering)
- May 27: 107K (−10K — minor dip, stabilizing in 103-117K range)
- June 1: 252K (+145K — FULLY RECOVERED to normal range)

[!success] PLATELETS STABLE NORMAL — June 6: 241K (SUSTAINED RECOVERY)
Platelets remain stable normal at 241K (−11K from June 1) — well within reference range (150-400K). This confirms sustained platelet recovery following the May 11-17 nadir (103-113K). MPV 10.4 (N) indicates normal platelet production. Bleeding risk remains RESOLVED.

Full recovery trajectory:
- May 11-17: 103-113K (nadir — thrombocytopenia, bleeding risk)
- May 23-27: 107-117K (early recovery)
- June 1: 252K (full recovery)
- June 6: 241K (stable normal — sustained)

Multi-lineage recovery sequence confirmed:
- Platelet recovery (May 11 nadir → June 1-6 stable normal)
- Hemoglobin recovery (May 17 nadir → June 6 normal 12.1 g/dL)
- WBC/ANC recovery (May 27-June 1 nadir → June 6 improving, WBC 2500, ANC 1240)

Platelets recovered first (~10-14 days ahead of granulocytes), as expected with Aza-Ven myelosuppression. All three cell lines now recovering coordinately. See Hemoglobin, Rbc Count, Anc, Wbc, Aml.